Seres Therapeutics, Inc. (MCRB)
Seres Therapeutics Market Cap : 14.37M for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 17, 2026 | 14.17M |
| November 16, 2026 | 14.17M |
| November 13, 2026 | 14.07M |
| November 12, 2026 | 14.17M |
| November 11, 2026 | 15.07M |
| November 10, 2026 | 15.68M |
| November 09, 2026 | 17.08M |
| November 06, 2026 | 19.90M |
| November 05, 2026 | 21.00M |
| November 04, 2026 | 21.00M |
| November 03, 2026 | 19.70M |
| November 02, 2026 | 18.39M |
| October 30, 2026 | 17.39M |
| October 29, 2026 | 19.16M |
| October 28, 2026 | 17.59M |
| October 27, 2026 | 17.69M |
| October 26, 2026 | 19.46M |
| October 23, 2026 | 20.54M |
| October 22, 2026 | 20.93M |
| October 21, 2026 | 22.60M |
| October 20, 2026 | 22.70M |
| October 19, 2026 | 23.78M |
| October 16, 2026 | 24.18M |
| October 15, 2026 | 24.86M |
| October 14, 2026 | 23.78M |
| Date | Value |
|---|---|
| October 13, 2026 | 24.86M |
| October 12, 2026 | 26.34M |
| October 09, 2026 | 26.63M |
| October 08, 2026 | 25.85M |
| October 07, 2026 | 26.73M |
| October 06, 2026 | 28.50M |
| October 05, 2026 | 28.01M |
| October 02, 2026 | 28.89M |
| October 01, 2026 | 28.79M |
| September 30, 2026 | 32.92M |
| September 29, 2026 | 34.20M |
| September 28, 2026 | 34.59M |
| September 25, 2026 | 34.59M |
| September 24, 2026 | 35.58M |
| September 23, 2026 | 37.25M |
| September 22, 2026 | 39.51M |
| September 21, 2026 | 40.00M |
| September 18, 2026 | 39.31M |
| September 17, 2026 | 40.29M |
| September 16, 2026 | 41.37M |
| September 15, 2026 | 45.21M |
| September 14, 2026 | 46.48M |
| September 11, 2026 | 49.24M |
| September 10, 2026 | 50.12M |
| September 09, 2026 | 51.89M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Agenus, Inc. | 288.88M |
| Amgen, Inc. | 240.05B |
| Anika Therapeutics, Inc. | 182.43M |
| BioCryst Pharmaceuticals, Inc. | 1.868B |
| Imunon, Inc. | 3.671M |
Market Cap Related Metrics
| PS Ratio | 6.539 |
| Price to Book Value | 0.6728 |
| Price | 1.43 |
| Earnings Yield | -338.8% |